awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37619710-D17662CA-0D14-4D36-A11D-D1B5DC695443
Q37619710-D17662CA-0D14-4D36-A11D-D1B5DC695443
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37619710-D17662CA-0D14-4D36-A11D-D1B5DC695443
Combination therapy with copanlisib and ABL tyrosine kinase inhibitors against Philadelphia chromosome-positive resistant cells.
P2860
Q37619710-D17662CA-0D14-4D36-A11D-D1B5DC695443
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37619710-D17662CA-0D14-4D36-A11D-D1B5DC695443
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31a118663538de1e98702d3b3fc20ecd8066d86a
P2860
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.